Skip to Content

  • Search

View Additional Section Content

0086P - A Three Arm Randomized Phase II Study of Paclitaxel/Carboplatin/Bevacizumab (NSC 704865, IND 7921) Paclitaxel/Carboplatin/Temsirolimus (NSC 683864, IND 61010) and Ixabepilone (NSC 710428, IND 59699) Carboplatin/Bevacizumab as Initial Therapy for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer

Clinical Trial Categories

  • Corpus Uterus/Endometrial Cancer
Contact
Hanjani Institute for Gynecologic Oncology at 215-885-0220

Location

  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details